288 related articles for article (PubMed ID: 35242707)
1. Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma.
Wu K; Yu B; Li D; Tian Y; Liu Y; Jiang J
Front Oncol; 2022; 12():805978. PubMed ID: 35242707
[TBL] [Abstract][Full Text] [Related]
2. Nanoplatforms: The future of oral cancer treatment.
Senevirathna K; Jayawickrama SM; Jayasinghe YA; Prabani KIP; Akshala K; Pradeep RGGR; Damayanthi HDWT; Hettiarachchi K; Dorji T; Lucero-Prisno DE; Rajapakse RMG; Kanmodi KK; Jayasinghe RD
Health Sci Rep; 2023 Aug; 6(8):e1471. PubMed ID: 37547360
[TBL] [Abstract][Full Text] [Related]
3. Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer.
Zhao Z; Li D; Wu Z; Wang Q; Ma Z; Zhang C
Front Pharmacol; 2020; 11():616101. PubMed ID: 33391000
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in nanoplatforms for the treatment of neuropathic pain.
Yu B; Wu K; Xu X; Liu Y; Jiang J
Spinal Cord; 2022 Jul; 60(7):594-603. PubMed ID: 35087202
[TBL] [Abstract][Full Text] [Related]
5. Recent advances of drug delivery nanocarriers in osteosarcoma treatment.
Wang SY; Hu HZ; Qing XC; Zhang ZC; Shao ZW
J Cancer; 2020; 11(1):69-82. PubMed ID: 31892974
[TBL] [Abstract][Full Text] [Related]
6. Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy.
Yang C; Merlin D
Nanomaterials (Basel); 2020 Jul; 10(7):. PubMed ID: 32708193
[TBL] [Abstract][Full Text] [Related]
7. Exosomes and osteosarcoma drug resistance.
Fu H; Wu Y; Chen J; Hu X; Wang X; Xu G
Front Oncol; 2023; 13():1133726. PubMed ID: 37007086
[TBL] [Abstract][Full Text] [Related]
8. Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment.
Gu X; Ding J; Zhang Z; Li Q; Zhuang X; Chen X
Curr Pharm Des; 2015; 21(36):5187-97. PubMed ID: 26412359
[TBL] [Abstract][Full Text] [Related]
9. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
Tanbour R; Martins AM; Pitt WG; Husseini GA
Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites.
Cao J; Huang D; Peppas NA
Adv Drug Deliv Rev; 2020 Dec; 167():170-188. PubMed ID: 32622022
[TBL] [Abstract][Full Text] [Related]
12. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.
Tian H; Cao J; Li B; Nice EC; Mao H; Zhang Y; Huang C
Bone Res; 2023 Feb; 11(1):11. PubMed ID: 36849442
[TBL] [Abstract][Full Text] [Related]
13. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
14. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers.
Gopalan D; Pandey A; Udupa N; Mutalik S
J Control Release; 2020 Mar; 319():183-200. PubMed ID: 31866505
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in phase change material based nanoplatforms for cancer therapy.
Cao C; Yang N; Dai H; Huang H; Song X; Zhang Q; Dong X
Nanoscale Adv; 2021 Jan; 3(1):106-122. PubMed ID: 36131875
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Nanoreactors as In Vivo Nanoplatforms for Cancer Therapy.
Mukerabigwi JF; Ge Z; Kataoka K
Chemistry; 2018 Oct; 24(59):15706-15724. PubMed ID: 29572992
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-Responsive Nanoplatform-Assisted Photodynamic Therapy Against Bacterial Infections.
Zhou Y; Deng W; Mo M; Luo D; Liu H; Jiang Y; Chen W; Xu C
Front Med (Lausanne); 2021; 8():729300. PubMed ID: 34604266
[TBL] [Abstract][Full Text] [Related]
19. Nanoplatform-based cascade engineering for cancer therapy.
Chen J; Zhu Y; Wu C; Shi J
Chem Soc Rev; 2020 Dec; 49(24):9057-9094. PubMed ID: 33112326
[TBL] [Abstract][Full Text] [Related]
20. Protein-based nanoplatforms for tumor imaging and therapy.
Liang K; Chen H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1616. PubMed ID: 31999083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
